PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
 
Br J Cancer. 2009 December 3; 101(Suppl 2): S55–S59.
Published online 2009 December 3. doi:  10.1038/sj.bjc.6605391
PMCID: PMC2790712

Uptake in cancer screening programmes: a priority in cancer control

Abstract

Achieving adequate levels of uptake in cancer screening requires a variety of approaches that need to be shaped by the characteristics of both the screening programme and the target population. Strategies to improve uptake typically produce only incremental increases. Accordingly, approaches that combine behavioural, organisational and other strategies are most likely to succeed. In conjunction with a focus on uptake, providers of screening services need to promote informed decision making among invitees. Addressing inequalities in uptake must remain a priority for screening programmes. Evidence informing strategies targeting low-uptake groups is scarce, and more research is needed in this area. Cancer screening has the potential to make a major contribution to early diagnosis initiatives in the United Kingdom, and will best be achieved through uptake strategies that emphasise wide coverage, informed choice and equitable distribution of cancer screening services.

Keywords: cancer screening, uptake, inequalities, earlier diagnosis, access

Cancer screening is an important element of any national strategy to improve early cancer diagnosis. The NAEDI initiative (Department of Health NAEDI Newsletter, 2009) emphasises a multi-faceted approach; there is a need to raise awareness of cancer symptoms and make health services better equipped to respond to symptoms. In parallel, effective and efficient cancer screening programmes based on sound evidence are needed. Indeed, cancer screening can effectively complement awareness and early diagnosis initiatives; a screening programme can, for example, raise awareness in the community of particular cancers and their associated symptoms.

Uptake (i.e. the proportion of screening invitees in a given year for whom a screening test result is recorded) is the most important factor in determining the success of a screening programme (Barratt et al, 2002; Parkin et al, 2008). The United Kingdom has, over recent decades, taken an organised, population-wide approach to screening; although the exact contribution of cancer screening to an observed reduction in mortality in the population can be difficult to quantify, modelling exercises suggest that cancer screening activity over recent decades has made a significant difference (Blanks et al, 2000; Raffle et al, 2003; Taylor et al, 2004; van der Aa et al, 2008). However, mortality reductions are brought about by many contributory factors and therefore combined approaches that include earlier presentation, more timely diagnosis and improved treatments are considered to hold the greatest promise of improved cancer outcomes (Department of Health NHS Cancer Plan, 2000).

Experience in the United Kingdom suggests that achieving and maintaining uptake in cancer screening requires ongoing effort; coverage (i.e. the proportion of resident and eligible individuals who have had a test with a recorded result in a screening round) can decline from one round of screening to the next, and the causes of this drop-off are often difficult to identify (Weller et al, 2007; Lancuck et al, 2008). A number of systematic reviews have examined the evidence supporting various approaches to cancer screening uptake (Jepson et al, 2000; Bonfill et al, 2001; Forbes et al, 2002). The findings typically vary according to factors such as cancer site, type of test and target population. However, organised recruitment strategies (the approach typically taken in the United Kingdom, which involves systematic recruitment and follow-up, the provision of scheduled appointments for screening), and personalised invitation approaches (for example, from a general practitioner) seem to show consistent benefits over opportunistic approaches to screening. Reducing structural barriers to accessing services (e.g. location, timing of appointments, childcare facilities) can also increase uptake (Baron et al, 2008).

It is timely, in this BJC issue, to examine the main predictors of uptake for the United Kingdom's three established cancer screening programmes (breast, cervical and colorectal screening), along with the evidence supporting strategies to improve uptake in each of these programmes.

Cervical screening

Variations in uptake

Recently, declining rates in cervical screening, particularly in younger women, have prompted renewed interest in the issue of adequate, population-wide coverage (Lancuck et al, 2008). Women from ethnic minorities and deprived sub-groups in the population have shown consistently lower uptake over decades of screening in countries worldwide (Webb et al, 2004; Moser et al, 2009) – particularly among groups born outside their host country (Downs et al, 2008). Health literacy is also an important determinant; the messages in cervical cancer screening recruitment materials are relatively complex, and strategies targeting invitees with limited health literacy require careful design and, ideally, flexibility in recruitment procedures (Giordano et al, 2008).

Strategies to improve uptake

While setting recruitment targets in UK primary care can lead to improved uptake, even in deprived populations (Baker and Middleton, 2003), interventions of proven sustainable benefit are typically multi-faceted, and result from efforts to make the approaches to target groups socially and culturally appropriate (Dietrich et al, 2006; Tu et al, 2006). The media has an important role to play in cervical screening through, for example, programme story-lines where a character has cancer (Meissner et al, 2004) in the United Kingdom this can produce profound short-term effects, although evidence for effectiveness in bringing about sustained increases is variable (Howe et al, 2002).

On-going effort, particularly targeting ethnic sub-groups, seems justified in the United Kingdom, although an ‘off-the-shelf' strategy remains elusive. Ideally, detailed socio-demographic and ethnic information should be available at local levels, to tailor strategies with local effect. The advent of HPV vaccination introduces a new dynamic into cervical screening uptake, and this will require further refinement of messages promoting uptake of screening over the next several years.

Breast screening

Variations in uptake

Socio-economic status is a powerful driver of uptake in breast screening, as shown in the recent National Statistics Omnibus Survey (Moser et al, 2009). Importantly, deprived populations seem to have later stage presentation in breast cancer-compounding the potential effects of inequalities of breast screening uptake (Cuthbertson et al, 2009). There is compelling evidence that certain ethnic sub-groups in the United Kingdom have lower participation rates than the general population (Szczepura et al, 2008).

Strategies to improve uptake

In common with other forms of screening, individuals vary in their response to a breast screening invitation; factors such as perceived risk of cancer and perceived ability to undertake the test are important, and interventions should ideally incorporate theoretical psychological models (Champion et al, 2007). Endorsement of breast screening from primary care seems to have a consistent, albeit modest, effect on recruitment (Bankhead et al, 2001). Research on targeting low-uptake groups has typically used customised approaches and, on balance, shows a beneficial effect – for example, strategies such as tailored telephone counselling seem to improve uptake (Luckmann et al, 2003). We should, however, be cautious about attempting more intense recruitment strategies across different regions of the United Kingdom – again, there is no one strategy with proven benefit in different contexts. While strategies such as phone calls and home visits can produce modest increases in breast cancer screening uptake, these efforts are labour intensive and may not be cost-effective on a population-wide scale in the United Kingdom (Kearins et al, 2009).

Colorectal screening

Variations in uptake

Colorectal screening, using the FOBT, is now being ‘rolled out' in all four countries of the United Kingdom. There is already compelling evidence that certain ethnic sub-groups in the United Kingdom have lower participation rates of colorectal screening than the general population – this applies to screening using both FOBT and flexible sigmoidoscopy (Robb et al, 2008; Szczepura et al, 2008). The reasons for these differences are complex, underpinned by a range of health beliefs and cultural attitudes; in some ethnic sub-groups participation in screening is at odds with cultural norms, and issues such as perceived lack of self-efficacy, cultural misunderstandings, barriers relating to spiritual beliefs and fear of cancer are all significant. Further, profound differences in uptake rates between socio-economic groups have emerged in countries adopting screening (Weller et al, 2007; Deutekom et al, 2009).

Colorectal screening is targeted at both males and females, and there is some evidence that males and younger age groups have lower uptake rates of FOBT screening (Weller et al, 2007; Pornet et al, 2009). However, the evidence is less clear for endoscopic procedures such as colonoscopy or flexible sigmoidoscopy (UK Flexible Sigmoidoscopy Screening Trial, 2002; Meissner et al, 2006). Men appear to have higher rates of participation, although there are exceptions, such as a recent population-based trial of flexible sigmoidoscopy screening from Norway (Hoff et al, 2009).

Again, literacy is a critical determinant of participation in colorectal cancer screening. A great deal of effort has been devoted to producing information and materials for the bowel cancer screening programmes, which are comprehensive, informative and balanced – yet we know that health literacy varies a great deal in the population (von Wagner et al, 2009b), and many invitees will have limited comprehension of recruitment materials.

Strategies to improve uptake

Again, interventions of proven benefit targeting deprived and ethnic sub-groups are typically multi-faceted, and result from efforts to make the approaches to target groups socially and culturally appropriate (Tu et al, 2006). The type of test used is also important. On the whole, tests that are simpler and which minimise factors such as cost, inconvenience and distaste (e.g. from handling faeces in faecal occult blood testing), are associated with greater uptake (Federici et al, 2005). Endorsement of cancer screening from primary care can improve uptake although, again, the effect is quite modest (Federici et al, 2006); evidence from the United States suggests that engagement of wider primary care teams is particularly promising (Hudson et al, 2007; Klabunde et al, 2007). Low primary care use has been associated with a lack of CRC screening among both women and men (Fenton et al, 2009).

As the current programme is implemented screening providers need to avoid the possibility of patterns of low uptake in ethnic and deprived groups becoming entrenched. We have the opportunity with a new programme to trial new, tailored and culturally appropriate approaches to these groups, and there is currently a great deal of research activity and innovation in this area. It is less clear whether specific effort should be directed at males as the differences in uptake are not large and appear to be less consistent in different regions of the United Kingdom. Nevertheless, methods of approach, which accommodate male perspectives and attitudes towards preventive health services, should be considered – these may differ considerably from those of women (Cullati et al, 2009), and require specific strategies to overcome gender-specific barriers to screening uptake.

The timing of invitations may also be worth considering – although it would require a substantial re-arrangement of current recruitment processes in the bowel screening programmes. It seems timing can have a positive effect, if invitations coincide with annual milestones such as birthdays and festivals (Hoff and Bretthauer, 2008). We so far have limited evidence supporting the use of web-based resources in promoting CRC screening in the United Kingdom, although US evidence suggests these approaches show promise, particularly, if they have a strong interactive component (Ruffin et al, 2007).

Summary

While other factors are important, ethnicity, social deprivation and gender are the major determinants of cancer screening uptake in United Kingdom cancer screening programmes – their effect on uptake is summarised in Table 1. Strategies to improve cancer screening uptake vary according to context, type of test and target group – a summary of evidence is shown in Table 2. There is a strong programme of research into cancer screening uptake in the United Kingdom, and new evidence is emerging; in this British Journal of Cancer supplement von Wagner et al (2009a) describe socio-economic patterns of uptake for FOBT screening in London. This adds to a growing body of literature showing that we need to invest extra efforts in reducing inequalities in cancer screening uptake. Further Eilbert et al (2009) provide an interesting model for improving uptake – carefully tailored to local context in their region of London, and involving multi-faceted approaches. Increasingly, these are the kinds of approaches we will need to improve uptake in an equitable way.

Table 1
Effect of deprivation, ethnicity and gender on uptake: examples from UK cancer screening programmesa
Table 2
Summary of interventions with some evidence of effectiveness in cancer screening

Ideally, the achievement of adequate uptake rates in cancer screening should be accompanied by informed uptake – that is, invitees should make informed choices and be aware of all the risks and benefits of participation (Jepson et al, 2005). It is a difficult concept to measure, and involves more than provision of information – it includes a need to check understanding and to explore decision making processes (Jepson et al, 2007; Woodrow et al, 2008). Increasingly, individuals invited to screening are encouraged to access and use more information to reach decisions over participation (Welch, 2004).

Conclusions

The reduction in health inequalities is a major feature of the Cancer Reform Strategy. Yet uptake of cancer screening is not uniform across the population – within the United Kingdom, variation in uptake in cancer screening programmes is observed in different population sub-groups: for both breast and cervical screening uptake is lower in deprived communities and in some black and ethnic minority communities; these same patterns are seen in the more recently introduced bowel screening programme, where gender has also been shown to affect participation.

Cancer screening uptake improvement strategies will continue to require careful and creative design; socio-demographic and cultural patterns of cancer screening uptake are well established, and though strategies for improving uptake differ according to the dynamics of the screening process, there are many generic lessons that are transferable between the different screening programmes. There is, for example, a small but growing body of evidence to shape strategies targeting ethnic and deprived populations, and both age- and gender-based sub-groups; however, there is a need to develop a robust evidence base for effective interventions for diverse populations within the United Kingdom.

Cancer screening should ideally work in tandem with other awareness and early diagnosis initiatives. The NAEDI initiative is part of a major push to further improve the United Kingdom's performance in cancer-related health outcomes (Department of Health Cancer Reform Strategy, 2007); cancer screening programmes with good coverage, well-informed invitees and equitable engagement of the population can have a major role.

Conflict of interest

The authors declare no conflict of interest.

References

  • Baker D, Middleton E. Cervical screening and health inequality in England in the 1990s. J Epidemiol Community Health. 2003;57:417–423. [PMC free article] [PubMed]
  • Bankhead C, Richards SH, Peters TJ, Sharp DJ, Hobbs FD, Brown J, Roberts L, Tydeman C, Redman V, Formby J, Wilson S, Austoker J. Improving attendance for breast screening among recent non-attenders: a randomised controlled trial of two interventions in primary care. J Med Screen. 2001;8:99–105. [PubMed]
  • Baron RC, Rimer BK, Coates RJ, Kerner J, Kalra GP, Melillo S, Habarta N, Wilson KM, Chattopadhyay S, Leeks K, Task Force on Community Preventive Services Client-directed interventions to increase community access to breast, cervical, and colorectal cancer screening: a systematic review. Am J Prev Med. 2008;35 1 Suppl:S56–S66. [PubMed]
  • Barratt A, Mannes P, Irwig L, Trevena L, Craig J, Rychetnik L. Cancer screening. J Epidemiol Community Health. 2002;56:899–902. [PMC free article] [PubMed]
  • Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990–1998: comparison of observed with predicted mortality. Br Med J. 2000;321:665–669. [PMC free article] [PubMed]
  • Bonfill X, Marzo M, Pladevall M, Martí J, Emparanza JI. 2001. Strategies for increasing women participation in community breast cancer screening Cochrane Database Syst Rev 1CD002943 . http://mrw.interscience.wiley.com/cochrane/clsysrev/
    articles/CD002943/frame.html
    [PubMed]
  • Champion V, Skinner CS, Hui S, Monahan P, Juliar B, Daggy J, Menon U. The effect of telephone vs print tailoring for mammography adherence. Patient Educ Couns. 2007;65:416–423. [PMC free article] [PubMed]
  • Cullati S, Charvet-Bérard AI, Perneger TV. Cancer screening in a middle-aged general population: factors associated with practices and attitudes. BMC Public Health. 2009;9:118. [PMC free article] [PubMed]
  • Cuthbertson SA, Goyder EC, Poole J. Inequalities in breast cancer stage at diagnosis in the Trent region, and implications for the NHS Breast Screening Programme. J Public Health (Oxf) 2009;31 3:398–405. [PubMed]
  • Department of Health 2000. The NHS cancer plan: a plan for investment, a plan for reform . http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/
    documents/digitalasset/dh_4014513.pdf
  • Department of Health 2007. Cancer reform strategy . http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/
    digitalasset/dh_081007.pdf
  • Department of Health and Cancer Research UK NAEDI Newsletter; National Awareness and Early Diagnosis Initiative. 2009.
  • Deutekom M, van Rijn AF, Dekker E, Blaauwgeers H, Stronks K, Fockens P, Essink-Bot ML. Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands. Eur J Public Health. 2009;19:400–402. [PubMed]
  • Dietrich AJ, Tobin JN, Cassells A, Robinson CM, Greene MA, Sox CH, Beach ML, DuHamel KN, Younge RG. Telephone care management to improve cancer screening among low-income women: a randomized, controlled trial. Ann Intern Med. 2006;144:563–571. [PubMed]
  • Downs LS, Smith JS, Scarinci I. The disparity of cervical cancer in diverse populations. Gynecol Oncol. 2008;109:S22–S30. [PubMed]
  • Eilbert KW, Carroll K, Peach J, Khatoon S, Basnett I, McCulloch N. Approaches to improving breast screening uptake: evidence and experience from Tower Hamlets. Br J Cancer. 2009;101 Suppl 2:S64–S67. [PMC free article] [PubMed]
  • Federici A, Giorgi RP, Bartolozzi F, Farchi S, Borgia P, Guastcchi G. The role of GPs in increasing compliance to colorectal cancer screening: a randomised controlled trial (Italy) Cancer Causes Control. 2006;17:45–52. [PubMed]
  • Federici A, Giorgi RP, Borgia P, Bartolozzi F, Farchi S, Gausticchi G. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial. J Med Screen. 2005;12:83–88. [PubMed]
  • Fenton JJ, Reid RJ, Baldwin LM, Elmore JG, Buist DS, Franks P. Influence of primary care use on population delivery of colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2009;18:640–645. [PMC free article] [PubMed]
  • Forbes C, Jepson R, Martin-Hirsch P. 2002. Interventions targeted at women to encourage the uptake of cervical screening Cochrane Database Syst Rev 3CD002834 . http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/
    CD002834/frame.html
    [PubMed]
  • Giordano L, Webster P, Anthony C, Szarewski A, Davies P, Arbyn M, Segnan N, Austoker J. Improving the quality of communication in organised cervical cancer screening programmes. Patient Educ Couns. 2008;72:130–136. [PubMed]
  • Hoff G, Bretthauer M. Appointments timed in proximity to annual milestones and compliance with screening: randomised controlled trial. Br Med J. 2008;337:a2794. [PMC free article] [PubMed]
  • Hoff G, Grotmol T, Skovlund E, Bretthauer M, for the Norwegian Colorectal Cancer Prevention Group Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. Br Med J. 2009;338:b1846. [PMC free article] [PubMed]
  • Howe A, Owen-Smith V, Richardson J. The impact of a television soap opera on the NHS Cervical Screening Programme in the North West of England. J Public Health Med. 2002;24:299–304. [PubMed]
  • Hudson SV, Ohman-Strickland P, Cunningham R, Ferrante JM, Hahn K, Crabtree BF. The effects of teamwork and system support on colorectal cancer screening in primary care practices. Cancer Detect Prev. 2007;31:417–423. [PMC free article] [PubMed]
  • Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J. The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol Assess. 2000;4:1–133. [PubMed]
  • Jepson RG, Hewison J, Thompson A, Weller D. Patient perspectives on information and choice in cancer screening: a qualitative study in the UK. Soc Sci Med. 2007;65:890–899. [PubMed]
  • Jepson RG, Hewison J, Thompson AG, Weller D. How should we measure informed choice? The case of cancer screening. J Med Ethics. 2005;31:192–196. [PMC free article] [PubMed]
  • Kearins O, Walton J, O'Sullivan E, Lawrence G. Invitation management initiative to improve uptake of breast cancer screening in an urban UK Primary Care Trust. J Med Screen. 2009;16:81–84. [PubMed]
  • Klabunde CN, Lanier D, Breslau ES, Zapka JG, Fletcher RH, Ransohoff DF, Winawer SJ. Improving colorectal cancer screening in primary care practice: innovative strategies and future directions. J Gen Intern Med. 2007;22:1195–1205. [PMC free article] [PubMed]
  • Lancuck L, Patnick J, Vessey M. A cohort effect in cervical screening coverage. J Med Screen. 2008;15:27–29. [PubMed]
  • Luckmann R, Savageau JA, Clemow L, Stoddard AM, Costanza ME. A randomized trial of telephone counseling to promote screening mammography in two HMOs. Cancer Detect Prev. 2003;27:442–450. [PubMed]
  • Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15:389–394. [PubMed]
  • Meissner HI, Smith RA, Rimer BK, Wilson KM, Rakowski W, Vernon SW, Briss PA. Promoting cancer screening: learning from experience. Cancer. 2004;101:1107–1117. [PubMed]
  • Moser K, Patnick J, Beral V. Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. Br Med J. 2009;338:b2025. [PMC free article] [PubMed]
  • Parkin DM, Tappenden P, Olsen AH, Patnick J, Sasieni P. Predicting the impact of the screening programme for colorectal cancer in the UK. J Med Screen. 2008;15:163–174. [PubMed]
  • Pornet C, Dejardin O, Morlais F, Bouvier V, Launoy G. 2009. Socioeconomic determinants for compliance to colorectal cancer screening. A multilevel analysis J Epidemiol Community Health[e-pub ahead of print] doi:10.1136/jech.2008.081117 [PubMed] [Cross Ref]
  • Raffle AE, Alden B, Quinn M, Babb PJ, Brett MT. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. Br Med J. 2003;326:901. [PMC free article] [PubMed]
  • Robb KA, Power E, Atkin W, Wardle J. Ethnic differences in participation in flexible sigmoidoscopy screening in the UK. J Med Screen. 2008;15:130–136. [PubMed]
  • Ruffin MT, Fetters MD, Jimbo M. Preference-based electronic decision aid to promote colorectal cancer screening: results of a randomized controlled trial. Prev Med. 2007;45:267–273. [PubMed]
  • Steele RJ, McClements PL, Libby G, Black R, Morton C, Birrell J, Mowat NA, Wilson JA, Kenicer M, Carey FA, Fraser CG. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut. 2009;58:530–535. [PubMed]
  • Szczepura A, Price C, Gumber A. Breast and bowel cancer screening uptake patterns over 15 years for UK south Asian ethnic minority populations, corrected for differences in socio-demographic characteristics. BMC Public Health. 2008;8:346. [PMC free article] [PubMed]
  • Taylor R, Morrell S, Estoesta J, Brassil A. Mammography screening and breast cancer mortality in New South Wales, Australia. Cancer Causes Control. 2004;15:543–550. [PubMed]
  • Tu SP, Taylor V, Yasui Y, Chun A, Yip MP, Acorda E, Li L, Bastani R. Promoting culturally appropriate colorectal cancer screening through a health educator: a randomized controlled trial. Cancer. 2006;107:959–966. [PubMed]
  • UK Flexible Sigmoidoscopy Screening Trial Investigators Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet. 2002;359:1291–1300. [PubMed]
  • van der Aa MA, Pukkala E, Coebergh JW, Anttila A, Siesling S. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer. 2008;122:1854–1858. [PubMed]
  • von Wagner C, Good A, Wright D, Rachet B, Obichere A, Bloom S, Wardle J. Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England. Br J Cancer. 2009a;101 Suppl 2:S60–S63. [PMC free article] [PubMed]
  • von Wagner C, Semmler C, Good A, Wardle J. Health literacy and self-efficacy for participating in colorectal cancer screening: the role of information processing. Patient Educ Couns. 2009b;75:352–357. [PubMed]
  • Webb R, Richardson J, Esmail A, Pickles A. Uptake for cervical screening by ethnicity and place-of-birth: a population-based cross-sectional study. J Public Health. 2004;26:293–296. [PubMed]
  • Welch HG. Should I be Tested for Cancer? Maybe not, and Here's why. University of California Press Ltd: London; 2004.
  • Weller D, Coleman D, Robertson R, Butler P, Melia J, Campbell C, Parker R, Patnick J, Moss S. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer. 2007;97:1601–1605. [PMC free article] [PubMed]
  • Woodrow C, Watson E, Rozmovits L, Parker R, Austoker J. Public perceptions of communicating information about bowel cancer screening. Health Expect. 2008;11:16–25. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK